INTRODUCTION: Congenital heart block (CHB) is a passively acquired autoimmune disease considered to be due to the transfer of maternal autoantibodies, anti-SSA/Ro -SSB/La, to the fetus resulting in atrioventricular (AV) block and sinus bradycardia. We previously established a murine model for CHB where pups born to immunized wild-type (WT) mothers exhibited electrocardiographic abnormalities similar to those seen in CHB and demonstrated inhibition of L-type Ca channels (LTCCs) by maternal antibodies. Here, we hypothesize that overexpression of LTCC should rescue, whereas knockout of LTCC should worsen the electrocardiographic abnormalities in mice. METHODS AND RESULTS: Transgenic (TG) mice were immunized with SSA/Ro and SSB/La antigens. Pups born to immunized WT mothers had significantly greater sinus bradycardia and AV block compared to pups from nonimmunized WT. TG pups overexpressing LTCC had significantly less sinus bradycardia and AV block compared to their non-TG littermates and to pups born to immunized WT mothers. All LTCC knockout pups born to immunized mothers had sinus bradycardia, advanced degree of AV block, and decreased fetal parity. No sinus bradycardia or AV block were manifested in pups from control nonimmunized WT mothers. IgG from mothers with CHB children, but not normal IgG, completely inhibited intracellular Ca transient ([Ca](i)T) amplitude. CONCLUSIONS: Cardiac-specific overexpression of LTCC significantly reduced the incidence of AV block and sinus bradycardia in pups exposed to anti-SSA/Ro -SSB/La autoantibodies, whereas exposure of LTCC knockout pups to these autoantibodies significantly worsened the electrocardiographic abnormalities. These findings support the hypothesis that maternal antibodies inhibit LTCC and [Ca](i)T thus contributing to the development of CHB. Altogether, the results are relevant to the development of novel therapies for CHB.
INTRODUCTION:Congenital heart block (CHB) is a passively acquired autoimmune disease considered to be due to the transfer of maternal autoantibodies, anti-SSA/Ro -SSB/La, to the fetus resulting in atrioventricular (AV) block and sinus bradycardia. We previously established a murine model for CHB where pups born to immunized wild-type (WT) mothers exhibited electrocardiographic abnormalities similar to those seen in CHB and demonstrated inhibition of L-type Ca channels (LTCCs) by maternal antibodies. Here, we hypothesize that overexpression of LTCC should rescue, whereas knockout of LTCC should worsen the electrocardiographic abnormalities in mice. METHODS AND RESULTS:Transgenic (TG) mice were immunized with SSA/Ro and SSB/La antigens. Pups born to immunized WT mothers had significantly greater sinus bradycardia and AV block compared to pups from nonimmunized WT. TG pups overexpressing LTCC had significantly less sinus bradycardia and AV block compared to their non-TG littermates and to pups born to immunized WT mothers. All LTCC knockout pups born to immunized mothers had sinus bradycardia, advanced degree of AV block, and decreased fetal parity. No sinus bradycardia or AV block were manifested in pups from control nonimmunized WT mothers. IgG from mothers with CHB children, but not normal IgG, completely inhibited intracellular Ca transient ([Ca](i)T) amplitude. CONCLUSIONS: Cardiac-specific overexpression of LTCC significantly reduced the incidence of AV block and sinus bradycardia in pups exposed to anti-SSA/Ro -SSB/La autoantibodies, whereas exposure of LTCC knockout pups to these autoantibodies significantly worsened the electrocardiographic abnormalities. These findings support the hypothesis that maternal antibodies inhibit LTCC and [Ca](i)T thus contributing to the development of CHB. Altogether, the results are relevant to the development of novel therapies for CHB.
Authors: M Boutjdir; L Chen; Z H Zhang; C E Tseng; F DiDonato; W Rashbaum; A Morris; N el-Sherif; J P Buyon Journal: Circ Res Date: 1997-03 Impact factor: 17.367
Authors: J N Muth; H Yamaguchi; G Mikala; I L Grupp; W Lewis; H Cheng; L S Song; E G Lakatta; G Varadi; A Schwartz Journal: J Biol Chem Date: 1999-07-30 Impact factor: 5.157
Authors: J P Buyon; R Hiebert; J Copel; J Craft; D Friedman; M Katholi; L A Lee; T T Provost; M Reichlin; L Rider; A Rupel; S Saleeb; W L Weston; M L Skovron Journal: J Am Coll Cardiol Date: 1998-06 Impact factor: 24.094
Authors: Sara B Seidelmann; Emily Smith; Lakshman Subrahmanyan; Daniel Dykas; Maen D Abou Ziki; Bani Azari; Fady Hannah-Shmouni; Yuexin Jiang; Joseph G Akar; Mark Marieb; Daniel Jacoby; Allen E Bale; Richard P Lifton; Arya Mani Journal: Circ Cardiovasc Genet Date: 2017-02
Authors: Zully Pedrozo; Alfredo Criollo; Pavan K Battiprolu; Cyndi R Morales; Ariel Contreras-Ferrat; Carolina Fernández; Nan Jiang; Xiang Luo; Michael J Caplan; Stefan Somlo; Beverly A Rothermel; Thomas G Gillette; Sergio Lavandero; Joseph A Hill Journal: Circulation Date: 2015-04-17 Impact factor: 29.690
Authors: Sabrina Meisgen; Malin Hedlund; Aurelie Ambrosi; Lasse Folkersen; Vijole Ottosson; David Forsberg; Gudny Ella Thorlacius; Luca Biavati; Linn Strandberg; Johannes Mofors; Daniel Ramskold; Sabrina Ruhrmann; Lauro Meneghel; William Nyberg; Alexander Espinosa; Robert Murray Hamilton; Anders Franco-Cereceda; Anders Hamsten; Tomas Olsson; Lois Greene; Per Eriksson; Kristina Gemzell-Danielsson; Stina Salomonsson; Vijay K Kuchroo; Eric Herlenius; Ingrid Kockum; Sven-Erik Sonesson; Marie Wahren-Herlenius Journal: Ann Rheum Dis Date: 2022-04-25 Impact factor: 27.973
Authors: Linn S Strandberg; Xuezhi Cui; Arianna Rath; Jie Liu; Earl D Silverman; Xiaoru Liu; Vinayakumar Siragam; Cameron Ackerley; Brenda Bin Su; Jane Yuqing Yan; Marco Capecchi; Luca Biavati; Alice Accorroni; William Yuen; Filippo Quattrone; Kalvin Lung; Edgar T Jaeggi; Peter H Backx; Charles M Deber; Robert M Hamilton Journal: PLoS One Date: 2013-09-09 Impact factor: 3.240